A combination of high concentrations of serum triglyceride and non-high-density-lipoprotein-cholesterol is a risk factor for cardiovascular disease in subjects with abnormal glucose metabolism - The Hoorn Study

被引:39
作者
Bos, G
Dekker, JM
Nijpels, G
de Vegt, F
Diamant, M
Stehouwer, CDA
Bouter, LM
Heine, RJ
机构
[1] Free Univ Amsterdam, Inst Res Extramural Med, Med Ctr, NL-1081 BT Amsterdam, Netherlands
[2] Radboud Univ Nijmegen Med Ctr, Dept Epidemiol & Biostat, Nijmegen, Netherlands
[3] Vrije Univ Amsterdam, Dept Endocrinol, Ctr Diabet, Med Ctr, Amsterdam, Netherlands
[4] Vrije Univ Amsterdam, Med Ctr, Inst Cardiovasc Res, Amsterdam, Netherlands
关键词
Type; 2; diabetes; triglycerides; non-HDL-cholesterol; cardiovascular disease; insulin-resistance;
D O I
10.1007/s00125-003-1141-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesis. Type 2 diabetes is not only associated with hyperglycaemia, but also with disorders of lipid metabolism. The aim of this study was to investigate the association of triglyceride and non-HDL-cholesterol concentrations with cardiovascular disease in subjects with normal and abnormal glucose metabolism. Methods. Subjects were 869 men and 948 women aged 50 to 75 who participated in the Hoorn Study, a population-based cohort study that started in 1989. Glucose metabolism was determined by a 75 g OGTT. High fasting triglyceride and non-HDL-cholesterol concentrations were defined as above the median of the study population. Results. After 10 years of follow-up, the age- and sex-adjusted hazard ratios for cardiovascular disease were 1.35 (1.11-1.64) and 1.71 (1.40-2.08) for high triglycerides and high non-HDL-cholesterol, respectively, after mutual adjustment. After stratification for glucose metabolism status, the hazard ratios for cardiovascular disease for non-HDL-cholesterol were 1.70 (1.31-2.21) in normal glucose metabolism and 1.56 (1.12-2.18) in abnormal glucose metabolism. Triglycerides were not a risk factor in subjects with normal glucose metabolism, with a hazard ratio of 0.94 (0.73-1.22), but in subjects with abnormal glucose metabolism, the hazard ratio for cardiovascular disease was 1.54 (1.07-2.22). In subjects with abnormal glucose metabolism, the hazard ratio for the combined presence of high triglycerides and non-HDL-cholesterol was 2.12 (1.35-3.34). Conclusion. Our data suggest that in people with abnormal glucose metabolism, but not in those with normal glucose metabolism, high triglyceride concentration could be associated with the risk of cardiovascular disease, particularly in people with high non-HDL-cholesterol.
引用
收藏
页码:910 / 916
页数:7
相关论文
共 35 条
  • [11] PLASMA TRIGLYCERIDE LEVEL AND MORTALITY FROM CORONARY HEART-DISEASE
    CRIQUI, MH
    HEISS, G
    COHN, R
    COWAN, LD
    SUCHINDRAN, CM
    BANGDIWALA, S
    KRITCHEVSKY, S
    JACOBS, DR
    OGRADY, HK
    DAVIS, CE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (17) : 1220 - 1225
  • [12] Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality
    Cui, YD
    Blumenthal, RS
    Flaws, JA
    Whiteman, MK
    Langenberg, P
    Bachorik, PS
    Bush, TL
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (11) : 1413 - 1419
  • [13] Similar 9-year mortality risks and reproducibility for the World Health Organization and American Diabetes Association glucose tolerance categories - The Hoorn study
    de Vegt, F
    Nijpels, G
    Dekker, JM
    Bouter, LM
    Stehouwer, CDA
    Heine, RJ
    [J]. DIABETES CARE, 2000, 23 (01) : 40 - 44
  • [14] Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population:: the Hoorn Study
    de Vegt, F
    Dekker, JM
    Ruhé, HG
    Stehouwer, CDA
    Nijpels, G
    Bouter, LM
    Heine, RJ
    [J]. DIABETOLOGIA, 1999, 42 (08) : 926 - 931
  • [15] HDL-cholesterol as a marker of coronary heart disease risk:: the Quebec cardiovascular study
    Després, JP
    Lemieux, I
    Dagenais, GR
    Cantin, B
    Lamarche, B
    [J]. ATHEROSCLEROSIS, 2000, 153 (02) : 263 - 272
  • [16] HYPERTRIGLYCERIDEMIA AS A RISK FACTOR OF CORONARY HEART-DISEASE MORTALITY IN SUBJECTS WITH IMPAIRED GLUCOSE-TOLERANCE OR DIABETES - RESULTS FROM THE 11-YEAR FOLLOW-UP OF THE PARIS PROSPECTIVE-STUDY
    FONTBONNE, A
    ESCHWEGE, E
    CAMBIEN, F
    RICHARD, JL
    DUCIMETIERE, P
    THIBULT, N
    WARNET, JM
    CLAUDE, JR
    ROSSELIN, GE
    [J]. DIABETOLOGIA, 1989, 32 (05) : 300 - 304
  • [17] Serum lipids and incidence of coronary heart disease - Findings from the systolic hypertension in the elderly program (SHEP)
    Frost, PH
    Davis, BR
    Burlando, AJ
    Curb, JD
    Guthrie, GP
    Isaacsohn, JL
    WassertheilSmoller, S
    Wilson, AC
    Stamler, J
    [J]. CIRCULATION, 1996, 94 (10) : 2381 - 2388
  • [18] Rationale for use of non-high-density lipoprotein cholesterol rather than low-density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy
    Frost, PH
    Havel, RJ
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (4A) : 26B - 31B
  • [19] MANAGEMENT OF DYSLIPIDEMIA IN NIDDM
    GARG, A
    GRUNDY, SM
    [J]. DIABETES CARE, 1990, 13 (02) : 153 - 169
  • [20] HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND CARDIOVASCULAR-DISEASE - 4 PROSPECTIVE AMERICAN-STUDIES
    GORDON, DJ
    PROBSTFIELD, JL
    GARRISON, RJ
    NEATON, JD
    CASTELLI, WP
    KNOKE, JD
    JACOBS, DR
    BANGDIWALA, S
    TYROLER, HA
    [J]. CIRCULATION, 1989, 79 (01) : 8 - 15